Atrial fibrillation in the pacemaker clinic

Canadian Journal of Cardiology

Volumn 19, Issue 5, 2003, Pages 492-494

  McLellan, Catherine S ^a   Abdollah, Hoshiar ^a   Brennan, F James ^a   Simpson, Christopher S ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Anticoagulants; Atrial fibrillation; Electrocardiography; Pacemakers; Pacing

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAPHY MONITORING; ELECTRONICS; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ATRIUM PACEMAKER; HEART LEFT VENTRICLE; HEART RHYTHM; HEART VENTRICLE PACING; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PREVALENCE; SENSITIVITY AND SPECIFICITY; THROMBOEMBOLISM; CANADA; ELECTROCARDIOGRAPHY; EVALUATION; FEMALE; HEART PACING; MALE; OUTPATIENT DEPARTMENT; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; RISK FACTOR; SINGLE BLIND PROCEDURE;

AMBULATORY CARE FACILITIES; ANTICOAGULANTS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; ONTARIO; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; WARFARIN;

EID: 0038351180     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation. N Engl J Med 1982;306:1018-22.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke. Stroke 1991;22:983-8.
3. Hart RG, Halperin JL. Atrial fibrillation and thromboembolism: A decade in stroke prevention. Ann Intern Med 1999;131:688-95.
4. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 2000;160:41-6.
5. Samsa GP, Matchar DB, Goldstein LB, et al. Quality of anticoagulation management among patients with atrial fibrillation: Results of a review of medical records from 2 communities. Arch Intern Med 2000;160:967-73.
6. Carlsson J, Miketic S, Dees G, Haun S, Cuneo A, Tebbe U. Stroke prevention practices in patients with atrial fibrillation and pacemaker therapy: Evidence for under-use of anticoagulation. Europace 2000;2:115-8.
7. Gage BF, Boechler M, Doggette AL, et al. Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation. Stroke 2000;31:822-7.
8. Adhiyaman V, Kamalakannan D, Oke A, Shah IU, White AD. Underutilization of antithrombotic therapy in atrial fibrillation. J R Soc Med 2000;93:138-40.
9. Cohen N, Almoznino-Sarafian D, Alon I, et al. Warfarin for stroke prevention still underused in atrial fibrillation: Patterns of omission. Stroke 2000;31:1217-22.
10. Whittle J, Wickenheiser L, Vendetti KN. Is warfarin under-used in the treatment of elderly persons with atrial fibrillation? Arch Intern Med 1997;157:1613.
11. Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med 1999;131:927-34.
12. Patel AM, Westveer DC, Man KC, Stewart JR, Frumin HI. Treatment of underlying atrial fibrillation: Paced rhythm obscures recognition. J Am Coll Cardiol 2000;36:784-7.
13. Sivakumaran S, Kavanagh K, Van Shaik A, Tsuyuki RT. Atrial fibrillation and flutter in the pacemaker clinic. Can J Cardiol 2001;17S:C313. (Abst)
14. Sparks PB, Mond HG, Kalman JM, Jayaprakash S, Lewis MA, Grigg LE. Atrial fibrillation and anticoagulation in patients with permanent pacemakers: Implications for stroke prevention. Pacing Clin Electrophysiol 1998;21:1258-67.
15. Langenfeld H, Grimm W, Maisch B, Kochsiek K. Atrial fibrillation and embolic complications in spaced patients. Pacing Clin Electrophysiol 1988;11:1667-72.